Searchable abstracts of presentations at key conferences in endocrinology

ea0046p14 | (1) | UKINETS2016

Perioperative carcinoid crisis during surgery-who benefits from octreotide?

ElGendy Khalil , Johnnson Sarah , French Jeremy , White Steven , Charnley Richard , Manas Derek , Wilson Colin

Introduction: Carcinoid crisis, as an entity is poorly defined, but can be seen in patients with small bowel NET tumours after open bowel surgery or tumour unrelated procedures as cardiovascular instability (CI). Recent evidence suggests that cardiovascular instability (CI) during NET surgery is more common than previously considered.Aims and methods: We audited the incidence of CI during procedures and determined the relationship to perioperative octreo...

ea0046p24 | (1) | UKINETS2016

Improving outcomes for patients with resectable small bowel NET tumours; 5 year experience from a tertiary centre

ElGendy Khalil , Johnson Sarah , French Jeremy , White Steven , Charnley Richard , Manas Derek , Wilson Colin

Introduction: There remains controversy about which patients benefit from removal of their primary small bowel tumour and whether this should be performed in a specialist tertiary referral hospital as an elective procedure. Part of the decision making and consenting process in patients with metastases will be a shared decision about surgery with the patient in light of symptoms, morbidity from surgery and survival. The aim of this study was to elucidate important institution s...

ea0080p1 | Abstracts | UKINETS2021

Setting up of a national liver transplant programme for neuroendocrine tumour liver metastases in UK and Ireland: opportunities for clinical study and research

Shah Tahir , Moore Joanna , Venkataraman Hema , Caplin Martyn , Smith Stacey , O'Toole Dermot , Hoti Emir , Dasari Bobby , Ford Samuel , Mazzaferro Vincenzo , Gibbs Paul , Manas Derek , Isaac John , Thorburn Douglas

Background: Transplantation for cancer indications is evolving rapidly in UK and Ireland. Liver transplantation [LT] for unresectable neuroendocrine tumour liver metastases [NET LM] is one of three new cancer indications. It has the potential to significantly improve survival outcomes however, transplant benefit has likely been achieved only by highly experienced Centre(s). Since eligible patients for transplantation also have excellent prognosis with standard management, care...